Enlivex Therapeutics Ltd share price logo

Enlivex Therapeutics Ltd

NASDAQ: ENLV

Small Cap

$0.82

+0.01

(+0.94%)

Live

as on

Enlivex Therapeutics Ltd Stock Performance

as on May 5, 2026 at 5:08 am IST

  • Day's Low

    Day's High

    $0.80
    $0.89
    downward going graph

    2.44%

    Downside

    8.54%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.66
    $2.10
    downward going graph

    19.51%

    Downside

    156.10%

    Upside

    downward going graph

Enlivex Therapeutics Ltd share price movements today

Previous Close
$0.82
Open
$0.88
Volume
1.3M
Day's Low - High
$0.80 - $0.89
52 Week Low - High
$0.66 - $2.10

Enlivex Therapeutics Ltd Historical Returns

1 Month Return
-14.29 %
3 Month Return
-25.82 %
1 Year Return
-21.54 %
3 Year Return
-70.75 %
5 Year Return
-92.68 %

Enlivex Therapeutics Ltd Stock Fundamentals & Key Indicators

Check Enlivex Therapeutics Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$196.7M

EPS (TTM)

-0.05

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0.03

Industry PE ratio

-4.310941704035875

PEG Ratio

0

EBITDA

-14.7M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

126.17%

Enlivex Therapeutics Ltd Stock Valuation

Track how Enlivex Therapeutics Ltd P/E has moved over time to understand its valuation trends.

Enlivex Therapeutics Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-13.02x)

June 30, 2021

Industry (-4.31x)

May 4, 2026

Today (0.03x)

May 4, 2026

Highest (-1.07x)

December 31, 2023

LowHigh

Today’s Price to Earnings Ratio: 0.03x

Enlivex Therapeutics Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Enlivex Therapeutics Ltd with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$196.7M-92.68%0.030.00%
BUY$39.5B125.06%74.5912.55%
BUY$107.8B97.31%27.7132.94%
NA$32.7BNA118.975.37%
BUY$73.5B44.57%17.1229.65%

Stock Returns calculator for Enlivex Therapeutics Ltd Stock including INR - Dollar returns

The Enlivex Therapeutics Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Enlivex Therapeutics Ltd investment value today

Current value as on today

₹88,922

Returns

-₹11,078

(-11.08%)

Returns from Enlivex Therapeutics Ltd Stock

-₹21,154 (-21.15%)

Dollar Impact

₹10,076 (+10.08%)

Analyst Recommendation on Enlivex Therapeutics Ltd Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Enlivex Therapeutics Ltd. Average target price of $20

Enlivex Therapeutics Ltd Share Price Target

Get share price movements and forecasts by analysts on Enlivex Therapeutics Ltd.

What analysts predicted

95.9%UPSIDE

Target Price

$20

Current Price

$0.82

Analyzed by

7 Analysts

Target

$20.00

Enlivex Therapeutics Ltd target price $20, a slight upside of 95.9% compared to current price of $0.82. According to 7 analysts rating.

Enlivex Therapeutics Ltd Stock’s Investor Sentiment and Interest

Search interest for Enlivex Therapeutics Ltd Stock has increased by 112% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:112% versus previous 30 day period

Enlivex Therapeutics Ltd Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
-
0
0
0
0
Operating Income
-5
-6
-3
-2
-3
-4
-3
-3
-2
-5
EBITDA
-5
-5
-3
-2
-2
-
-3
-2
-2
-5
Interest Expense
-
-
-
0
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-5
-9
-4
-3
-2
-5
-3
-1
-2
1,625
Income Tax Expense
0
0
0
-
-
-
-
-
-
382
Net Income
-5
-9
-4
-3
-2
-5
-3
-1
-2
1,243
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Enlivex Therapeutics Ltd Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
2
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-15
-5
-5
-8
-9
-19
-25
-29
-15
-15
EBITDA
-15
-5
-5
-9
-9
-18
-25
-28
-14
-14
Interest Expense
-
-
-
0
0
0
5
0
0
0
Depreciation
-
0
0
0
0
0
0
0
0
0
Income Before Tax
-15
-5
-4
-9
-11
-14
-31
-29
-15
1,618
Income Tax Expense
0
0
1
0
2
-4
11
4
-
382
Net Income
-16
-5
-4
-9
-11
-14
-31
-29
-15
1,235
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
-519.28%
0.00%
0.00%
0.00%
0.00%
0.00%

Enlivex Therapeutics Ltd Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-9
-4
-3
-2
-5
-3
-1
-2
1,243
Operating Cash Flow
-5
-4
-1
-2
-4
-4
-1
-2
-2
Investing Cash Flow
4
5
0
1
-
3
1
4
-9
Financing Cash Flow
0
0
4
0
1
0
0
0
10
Change in Cash
-1
1
1
0
0
-1
0
2
-2

Enlivex Therapeutics Ltd Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-5
-4
-9
-11
-14
-31
-29
-15
1,235
Operating Cash Flow
-6
-3
-7
-11
-17
-23
-23
-13
-10
Investing Cash Flow
3
0
-6
-20
-38
62
-25
9
-1
Financing Cash Flow
0
5
8
33
60
0
0
6
10
Change in Cash
-3
0
-4
1
4
38
-49
2
-1

Global Institutional Holdings in Enlivex Therapeutics Ltd

Funds
Holdings
Morgan Stanley - Brokerage Accounts
0.08%
Bank of America Corp
0.04%
Jane Street Group LLC
0.03%
Citadel Advisors Llc
0.03%
XTX Topco Ltd
0.02%

Insights on Enlivex Therapeutics Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 15.8% return, outperforming this stock by 37.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Enlivex Ltd has experienced a drawdown of -70.8%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 63.8%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, ENLV stock has moved down by -7.5%

About Enlivex Therapeutics Ltd

Enlivex Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. It offers AllocetraTM, a cell therapy designed to restore macrophage homeostasis, as well as develops AllocetraTM intra-articular injection for the treatment of knee osteoarthritis, which is in phase 1/2 trial; intra-articular AllocetraTM in osteoarthritis of the temporomandibular joint (TMJ); and Allocetra-OTS for the treatment of organ failure in adult sepsis patients, which is in phase 2. Enlivex Ltd. was formerly known as Enlivex Therapeutics Ltd. and changed its name to Enlivex Ltd. in February 2026. The company was founded in 2005 and is headquartered in Ness Ziona, Israel.
OrganisationEnlivex Therapeutics Ltd
Headquarters14 Einstein Street, Ness Ziona, Israel, 7403618
IndustryBiotechnology
CEODr. Oren Hershkovitz Ph.D.
E-voting on sharesClick here to vote

Key Management of Enlivex Therapeutics Ltd

Name

Title

Prof. Dror Mevorach M.D.

Founder & Scientific Advisor

Ms. Shachar Shlosberger CPA

Chief Financial Officer

Dr. Veronique Amor-Baroukh

Senior Director of Operations

Ms. Sigal Arad

Director of Human Resources

Dr. Einat Galamidi M.D.

Chief Medical Officer

Mr. Shai Novik M.B.A.

Executive Chairman

Dr. Oren Hershkovitz Ph.D.

Chief Executive Officer

FAQs

What is Enlivex Therapeutics Ltd share price today?

Enlivex Therapeutics Ltd share price today is $0.82 as on . Enlivex Therapeutics Ltd share today touched a day high of $0.89 and a low of $0.8.

What is the 52 week high and 52 week low for Enlivex Therapeutics Ltd share?

Enlivex Therapeutics Ltd share touched a 52 week high of $2.1 on and a 52 week low of $0.66 on . Enlivex Therapeutics Ltd stock price today i.e. is trending at $0.82,which is 60.95% down from its 52 week high and 24.24% up from its 52 week low.

What is Enlivex Therapeutics Ltd's market capitalisation today?

Enlivex Therapeutics Ltd market capitalisation is $0.00T as on .

How to invest in Enlivex Therapeutics Ltd Stock (ENLV) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Enlivex Therapeutics Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Enlivex Therapeutics Ltd Shares that will get you 1.8293 shares as per Enlivex Therapeutics Ltd share price of $0.82 per share as on May 4, 2026 at 11:38 pm IST.

What is the minimum amount required to buy Enlivex Therapeutics Ltd Stock (ENLV) from India?

Indian investors can start investing in Enlivex Therapeutics Ltd (ENLV) shares with as little as ₹95.067 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹950.67 in Enlivex Therapeutics Ltd stock (as per the Rupee-Dollar exchange rate as on ). Based on Enlivex Therapeutics Ltd share’s latest price of $0.82 as on May 4, 2026 at 11:38 pm IST, you will get 12.1951 shares of Enlivex Therapeutics Ltd. Learn more about fractional shares .

What are the returns that Enlivex Therapeutics Ltd has given to Indian investors in the last 5 years?

Enlivex Therapeutics Ltd stock has given -92.68% share price returns and 28.57% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?